Semaglutide 8mg Injection Pen Kit
Synedica Semaglutide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Ozempic,” semaglutide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of GLP-1, a natural hormone that makes humans feel full from eating much smaller portions of food.
The Synedica Semaglutide® 1mg Injection Pen Kit contains 2 pens, 12 disposable needles and an instruction booklet.
Each pen has 4mg which can be delivered across 4 full doses of 1mg, or in increments of 0.25mg, 0.5mg, 0.75mg or 1mg.
Recommended dosage is 0.25mg for the first 4 weeks, then 0.5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 0.75mg or 1mg.
Notice
All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.
Suitable R&D Applications
Stability Testing
Thermal, enzymatic, and oxidative degradation studies
Shelf-life evaluation & formulation robustness
Formulation Development
Enhances solubility, bioavailability, and structural integrity
Tailored for injectable, topical, and research-grade use
Excipient Compatibility Testing
Evaluates interactions between peptides & inactive components
Ensures safety, stability, and performance
Protease Resistance Evaluation
Assesses susceptibility to enzymatic breakdown
Supports development of more durable peptide products
Encapsulation & Carrier Systems
Liposomes, microspheres, and other delivery vehicles
Protects peptides & enables controlled release
Administration Route Assessment
Optimized for:
Parenteral delivery (injectables)
Dermal absorption (cosmetic/topical)
In vitro research applications